OrSense, located in Ness Ziona in central Israel, recently presented its non-invasive hemoglobin (Hb) screening device for use in blood collection centers at the American Association of Blood Banks annual meeting. Results showed accurate performance of the device.
OrSense develops monitors for non-invasive measurements of various blood parameters. Its most recent screening device is NBM-200.
NBM-200 offers a unique, breakthrough, non-invasive solution for accurate and quick Hb measurements. Rather than relying on the traditional finger-prick method, the device operates via a ring-shaped sensor that is fitted on the donor’s finger and applies pressure, temporarily obstructing local blood flow.
Optical elements in the sensor perform a sensitive measurement of the light transmitted through the finger. This method, called Occlusion Spectroscopy, provides a quick, accurate and painless measurement of the donor’s blood constituents, while greatly improving the donor’s comfort, eliminating infection risk and bio-hazardous waste and providing the medical staff with accurate readings and immediate results.
Hb measurements allow the detection of anemia and hemorrhage, ensure adequate Hb content of blood units and are widely used by hospitals in operating rooms, ICU, ER and delivery rooms.
The product will be submitted for FDA review in the coming months.